You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API benztropine mesylate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing benztropine mesylate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Akorn BENZTROPINE MESYLATE benztropine mesylate 17478-012 SODIUM CHLORIDE
Akorn BENZTROPINE MESYLATE benztropine mesylate 17478-012 WATER
TYA Pharmaceuticals BENZTROPINE MESYLATE benztropine mesylate 64725-0012 SODIUM CHLORIDE
TYA Pharmaceuticals BENZTROPINE MESYLATE benztropine mesylate 64725-0012 WATER
Oak Pharmaceuticals Inc (Subsidiary of Akorn Inc) COGENTIN benztropine mesylate 76478-611 SODIUM CHLORIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing benztropine mesylate

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc benztropine mesylate 0143-9233 SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc benztropine mesylate 0143-9233 WATER
Hikma Pharmaceuticals USA Inc benztropine mesylate 0143-9729 SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc benztropine mesylate 0143-9729 WATER
Par Pharmaceutical Inc benztropine mesylate 0603-2433 CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for benztropine mesylate

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

benztropine mesylate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc benztropine mesylate 0143-9233
Hikma Pharmaceuticals USA Inc benztropine mesylate 0143-9729
Par Pharmaceutical Inc benztropine mesylate 0603-2437
NCS HealthCare of KY Inc dba Vangard Labs benztropine mesylate 0615-2547
NCS HealthCare of KY Inc dba Vangard Labs benztropine mesylate 0615-7676
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: CELLULOSE, MICROCRYSTALLINE

benztropine mesylate drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Par Pharmaceutical Inc benztropine mesylate 0603-2433
Par Pharmaceutical Inc benztropine mesylate 0603-2437
NCS HealthCare of KY Inc dba Vangard Labs benztropine mesylate 0615-2547
NCS HealthCare of KY LLC dba Vangard Labs benztropine mesylate 0615-8210
NCS HealthCare of KY LLC dba Vangard Labs benztropine mesylate 0615-8222
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CORN OIL

Excipient focus: CROSCARMELLOSE SODIUM

benztropine mesylate drug variants containing CROSCARMELLOSE SODIUM

Company Ingredient NDC
Par Pharmaceutical Inc benztropine mesylate 0603-2433
NCS HealthCare of KY Inc dba Vangard Labs benztropine mesylate 0615-7676
NCS HealthCare of KY LLC dba Vangard Labs benztropine mesylate 0615-8222
NCS HealthCare of KY LLC dba Vangard Labs benztropine mesylate 0615-8223
Upsher-Smith Laboratories LLC benztropine mesylate 0832-1080
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C RED NO. 40 ALUMINUM LAKE

Excipient focus: FD&C YELLOW NO. 5 ALUMINUM LAKE

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K12

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: TALC

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group